$3.90▾ 1.27%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
Term-debt data is not available for this company.
More coming: dilution / share-count creep.
✦ The read
Neuphoria Therapeutics Inc.'s earnings-quality signal is not available yet.
Key numbers
Valuation
EPS (TTM)$1.28
TTM (trailing 12 months, through fiscal Q3 FY2026)
Profitability
Net margin18.1%
TTM (trailing 12 months, through fiscal Q3 FY2026)
Size
Revenue (TTM)$15.00M
TTM (trailing 12 months, through fiscal Q3 FY2026)
Recent news
Sentiment · last 30 days1 article
0 bullish0 neutral1 bearish
Signals and key numbers are from the fiscal Q3 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.